Antimicrobial resistance: More quick action is needed in BRICS and MINT economic transition countries

  03 October 2019

Antimicrobial resistance (AMR) is an urgent public health issue, as resistant genes and pathogens will cross borders and spread without action, threatening medical progress. Breakthrough drugs and treatments, particularly those causing immunosuppression or requiring invasive procedures, will be useless if patients receiving them die from untreatable infections. This challenge requires multidisciplinary integrated collaboration and cooperation at the global level.

Further reading: The BMJ Opinion
Effective Surveillance  

Display your AMR technology / product:

Global AMR Technologies Database

  • Preventive – Diagnostic – Antimicrobial technologies
  • Academia – Research Institutes – Start ups – SMEs – Multinationals
  • Early research <-> near market
  • Global reach for funding / co-development / licensing
Display your technology and make use of the Continuous AMR Partnering Initiative >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!